Moderna Ceo
- All
- News
- Videos
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
Moderna CEO Says World May Need New Vaccines To Fight Omicron
Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned Tuesday, as countries ramp up vaccination programmes and impose further restrictions to curb growing concern.
-
Moderna CEO Warns COVID-19 Shots Less Effective Against Omicron
Drugmaker Moderna set off fresh alarm bells in financial markets on Tuesday as the firm's chief warned that COVID-19 vaccines are unlikely to be as effective against the Omicron variant as they have been against the Delta version.
-
Moderna Shot Could Start Being Used In Children, Teens Within Weeks: CEO
Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in an interview ahead of the Reuters Total Health conference, which will run virtually from Nov. 15-18.
-
Must Vaccinate Those At Risk With Third Dose, Says Moderna Chief: Report
Vaccination with a booster shot among as many people as possible is a good way to protect those most at risk against ever-emerging new coronavirus variants, Moderna CEO Stephane Bancel said on Sunday.
-
Moderna CEO Says Vaccine Likely To Protect For "Couple Of Years"
Moderna's COVID-19 mRNA vaccine is likely to offer protection of up to a couple of years, its chief executive said on Thursday, even though more data is still needed to make a definitive assessment.
-
Oxford Vaccine Will Protect 95 Per Cent, Says AstraZeneca CEO: Report
The Oxford coronavirus vaccine will "protect 95 per cent of patients" and is "as effective as the Pfizer and Moderna" alternatives, Pascal Soriot, the chief executive of AstraZeneca, told British daily The Sunday Times
-
Moderna To Charge $25-$37 Per Dose For Its COVID-19 Vaccine, Says CEO
Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).
-
Moderna's Coronavirus Vaccine Won't Be Ready Before US Elections: Report
US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
Moderna CEO Says World May Need New Vaccines To Fight Omicron
Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned Tuesday, as countries ramp up vaccination programmes and impose further restrictions to curb growing concern.
-
Moderna CEO Warns COVID-19 Shots Less Effective Against Omicron
Drugmaker Moderna set off fresh alarm bells in financial markets on Tuesday as the firm's chief warned that COVID-19 vaccines are unlikely to be as effective against the Omicron variant as they have been against the Delta version.
-
Moderna Shot Could Start Being Used In Children, Teens Within Weeks: CEO
Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in an interview ahead of the Reuters Total Health conference, which will run virtually from Nov. 15-18.
-
Must Vaccinate Those At Risk With Third Dose, Says Moderna Chief: Report
Vaccination with a booster shot among as many people as possible is a good way to protect those most at risk against ever-emerging new coronavirus variants, Moderna CEO Stephane Bancel said on Sunday.
-
Moderna CEO Says Vaccine Likely To Protect For "Couple Of Years"
Moderna's COVID-19 mRNA vaccine is likely to offer protection of up to a couple of years, its chief executive said on Thursday, even though more data is still needed to make a definitive assessment.
-
Oxford Vaccine Will Protect 95 Per Cent, Says AstraZeneca CEO: Report
The Oxford coronavirus vaccine will "protect 95 per cent of patients" and is "as effective as the Pfizer and Moderna" alternatives, Pascal Soriot, the chief executive of AstraZeneca, told British daily The Sunday Times
-
Moderna To Charge $25-$37 Per Dose For Its COVID-19 Vaccine, Says CEO
Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).
-
Moderna's Coronavirus Vaccine Won't Be Ready Before US Elections: Report
US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday.
